<?xml version="1.0" encoding="UTF-8"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title><![CDATA[The Globe and Mail]]></title><link>https://www.theglobeandmail.com</link><atom:link href="https://www.theglobeandmail.com/arc/outboundfeeds/rss/author/JenniferYang/" rel="self" type="application/rss+xml"/><description><![CDATA[The Globe and Mail News Feed]]></description><lastBuildDate>Wed, 22 Apr 2026 03:55:17 +0000</lastBuildDate><language>en-ca</language><copyright>Copyright 2024 The Globe and Mail Inc. All rights reserved.</copyright><ttl>1</ttl><sy:updatePeriod>hourly</sy:updatePeriod><sy:updateFrequency>1</sy:updateFrequency><image><url>https://www.theglobeandmail.com/legacy/static/mobile.flag.rss.png</url><title>The Globe and Mail</title><link>https://www.theglobeandmail.com</link></image><item><title><![CDATA[Canadian lab explains puzzling link between semaglutide, better liver health]]></title><link>https://www.theglobeandmail.com/canada/article-canadian-lab-semaglutide-liver-mystery-research/</link><guid isPermaLink="true">https://www.theglobeandmail.com/canada/article-canadian-lab-semaglutide-liver-mystery-research/</guid><dc:creator><![CDATA[Jennifer Yang]]></dc:creator><description><![CDATA[‘Impressive’ research answers mystery for scientists studying liver benefits of blockbuster GLP-1 drugs]]></description><pubDate>Tue, 14 Apr 2026 15:07:34 +0000</pubDate><content:encoded><![CDATA[<img src="https://www.theglobeandmail.com/resizer/v2/ZOMPNPAATFDMFIAEHMSCYPPYJY.JPG?auth=dea899f240b9aefa987538bf16dd33cc60518b0d42a3a431219d821fd2835164&smart=true&width=5000&height=3333" alt="Endocrinologist Dr. Daniel Drucker, pictured in Toronto last October, and his research team used mouse models and sophisticated technologies to explain the link between GLP-1 drugs and improved liver function." height="3333" width="5000"/>]]></content:encoded><media:content url="https://www.theglobeandmail.com/resizer/v2/ZOMPNPAATFDMFIAEHMSCYPPYJY.JPG?auth=dea899f240b9aefa987538bf16dd33cc60518b0d42a3a431219d821fd2835164&amp;smart=true&amp;width=5000&amp;height=3333" type="image/jpeg" height="3333" width="5000"><media:description type="plain"><![CDATA[Endocrinologist Dr. Daniel Drucker, pictured in Toronto last October, and his research team used mouse models and sophisticated technologies to explain the link between GLP-1 drugs and improved liver function.]]></media:description><media:credit role="author" scheme="urn:ebu">Sammy Kogan</media:credit></media:content></item></channel></rss>